Publications by authors named "John Burthem"

Claim this Profile
T
Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.
Stéphanie E Reitsma, Lori A Holle, Emma G Bouck, Dougald M Monroe, Alan E Mast, John Burthem

J Thromb Haemost· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Use and Effectiveness of an Online Diagnostic Support System for Blood Film Interpretation: Comparative Observational Study.
Claire Hutchinson, Michelle Brereton, Julie Adams, Barbara De La Salle, Jon Sims, John Burthem

J Med Internet Res· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A diagnostic evaluation of single screen testing for malaria in the returning traveler: A large retrospective cohort study.
Charles Reynard, Katie Geary, Peter Chiodini, Michelle Brereton, John Burthem

Acad Emerg Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switchable foldamer ion channels with antibacterial activity.
Anna D Peters, Stefan Borsley, Flavio Della Sala, Dominic F Cairns-Gibson, Marios Leonidou, John Burthem

Chem Sci· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Assay of Mutated Nucleophosmin in Acute Myeloid Leukemia.
Safaa A A Khaled, John Burthem, El-Badry E Abo Elnoor, Lobna F ElToni, Hanan M Ahmed

J Hematol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual-action CXCR4-targeting liposomes in leukemia: function blocking and drug delivery.
Catriona McCallion, Anna D Peters, Andrew Booth, Karen Rees-Unwin, Julie Adams, John Burthem

Blood Adv· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological activity of a CXCR4-targeting bis(cyclam) lipid.
Anna D Peters, Catriona McCallion, Andrew Booth, Julie A Adams, Karen Rees-Unwin, John Burthem

Org Biomol Chem· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASP2215 in the treatment of relapsed/refractory acute myeloid leukemia with FLT3 mutation: background and design of the ADMIRAL trial.
Claudia M Gorcea, John Burthem, Eleni Tholouli

Future Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency.
Gillian N Gidley, Lori A Holle, John Burthem, Paula H B Bolton-Maggs, Feng-Chang Lin

Blood Adv· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Successful management of acute myeloid leukaemia in a twin pregnancy - a case report.
David J M Routledge, Clare Tower, Elizabeth Davies, Martin Scott, Marie Waller, John Burthem

Br J Haematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Nucleophosmin Gene Mutation in Leukemogenesis of Acute Myeloid Leukemia.
Safaa A A Khaled, John Burthem, El-Badry E Abo Elnoor, Lobna F ElToni, Hanan M Ahmed

J Hematol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Web-Based Virtual Microscopy of Digitized Blood Slides for Malaria Diagnosis: An Effective Tool for Skills Assessment in Different Countries and Environments.
Laura Ahmed, Leonard H Seal, Carol Ainley, Barbara De la Salle, Michelle Brereton, John Burthem

J Med Internet Res· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Graphene in therapeutics delivery: Problems, solutions and future opportunities.
Catriona McCallion, John Burthem, Karen Rees-Unwin, Alexander Golovanov, Alain Pluen

Eur J Pharm Biopharm· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do We Know Why We Make Errors in Morphological Diagnosis? An Analysis of Approach and Decision-Making in Haematological Morphology.
Michelle Brereton, Barbara De La Salle, John Ardern, Keith Hyde, John Burthem

EBioMedicine· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sample conditions determine the ability of thrombin generation parameters to identify bleeding phenotype in FXI deficiency.
Gillian N Pike, Anthony M Cumming, Charles R M Hay, Paula H B Bolton-Maggs, John Burthem

Blood· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erythrophagocytosis of myeloblasts in acute myeloid leukaemia exhibiting chromosome 8p abnormality and extramedullary disease.
Theingi Yin, John Burthem, Amy McAlpine, Nick Telford

Br J Haematol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein.
Sarah Brown, Claire V Hutchinson, Mark Aspinall-O'Dea, Anthony D Whetton, Suzanne M Johnson, John Burthem

Eur J Haematol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-cell analysis of K562 cells: an imatinib-resistant subpopulation is adherent and has upregulated expression of BCR-ABL mRNA and protein.
Ehsan Ghayoor Karimiani, Fiona Marriage, Anita J Merritt, John Burthem, Richard John Byers

Exp Hematol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphocytes from chronic lymphocytic leukaemia undergo ABL1-linked amoeboid motility and homotypic interaction as an early adaptive change to ex vivo culture.
Claire V Hutchinson, Shiva Natarajan, Suzanne M Johnson, Julie A Adams, Karen S Rees-Unwin, John Burthem

Exp Hematol Oncol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal prion protein is expressed on exosomes isolated from human plasma.
Adam J Ritchie, Damian M Crawford, David J P Ferguson, John Burthem, David J Roberts

Br J Haematol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia.
Karen S Rees-Unwin, Robin Faragher, Richard D Unwin, Julie Adams, Philip J Brown, John Burthem

Br J Haematol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stage IV adult sporadic Burkitt lymphoma/leukemia with complex bone marrow cytogenetics is associated with a very poor outcome.
Eleni Tholouli, Simon Watt, Guy S Lucas, John Burthem, John A Liu Yin

Blood· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes following 50 mg versus 100 mg alemtuzumab in reduced-intensity conditioning stem cell transplants for acute myeloid leukaemia and poor risk myelodysplasia.
Eleni Tholouli, Effie Liakopoulou, Hayley M Greenfield, Bronwen E Shaw, Sudhir Tauro, John Burthem

Br J Haematol· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxycarbamide associated platelet count oscillations in a patient with polycythaemia vera. A case report and review of the literature.
John Burthem, Mohammed Suhail Chaudhry

Platelets· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemia.
Stephen D Griffiths, John Burthem, Richard D Unwin, Tessa L Holyoake, Junia V Melo

Mol Biotechnol· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis